This series of free online events from The Michael J. Fox Foundation is designed for researchers and clinicians. Each session features presentations on a hot topic in Parkinson’s research and therapeutic development from leaders in the field as well as opportunity for discussion and questions.
View Our Booklet to Support Your R&D
The Michael J. Fox Foundation has developed a free booklet for all attendees of the 2021 Parkinson's Disease Therapeutics Webinar series. The booklet provides an overview of the 2021 webinar series, resources for researchers and opportunities to stay connected with our Foundation.
Stay Up to Date
Join our email list for researchers and clinicians for the latest on upcoming webinars, funding opportunities, new resources (tools, datasets, biospecimens) and relevant news to accelerate research and patient care.
Past Webinars Available on Demand
Patient-Focused Drug Development: Novel Instruments to Capture Patient Outcomes in Parkinson’s
Assessments that meaningfully measure the patient experience are critical tools for clinical trials. This session focuses on MJFF-funded research to identify the symptoms and aspects of disease burden that matter to people living with Parkinson’s.
Molecular Signatures of Parkinson’s Disease
MJFF’s landmark study, the Parkinson’s Progression Markers Initiative (PPMI) has generated a large set of biological, clinical and imaging data to inform translational biomarker research as well as novel therapeutic development. This session delves into the available data and shares some of the key insights to date from analysis of the PPMI dataset.
The Many Faces of Parkinson's
This virtual “patient day” brings together industry professionals, people with Parkinson’s and care partners to share experiences of Parkinson’s; its varying onset, progression, and symptoms; and unmet needs.
Where We Are & Where We Are Heading: A Look Ahead at Therapeutic Development in Parkinson’s
Leaders from academia and industry discuss the momentum in our field and look ahead to what’s next. The panel covers therapeutic development from identifying novel targets through advancing compounds to the clinic with an emphasis on emerging trends and opportunities to accelerate future development.
The Promise of Precision Medicine for Parkinson’s Disease
Panelists discuss clinical heterogeneity in Parkinson’s disease; using genetic, biologic and pathologic signatures for designing clinical trials; and precision medicine approaches for Parkinson’s.
Using Patient Voices to Transform Your Parkinson's Research
Panelists discuss why it’s critical to bring patients and care partners into the research & development process early and often.
Centering Equity and Inclusion to Advance PD Therapeutic Development
Panelists discuss approaches to make Parkinson’s research more inclusive, ensuring on-time recruitment and representative trial populations.
Diverse Approaches Accelerating PD Target and Drug Screening
Part 1 of Innovating from Drug Discovery through the Clinic: Novel Approaches to PD Therapeutic Development
Panelists discuss how technologies — including DNA-encoded libraries, predictive AI-powered programs, and optogenetics — are fueling advances in drug discovery for Parkinson’s.
Progress in the PD Pipeline: A Snapshot of MJFF’s Funded Programs
Part 2 of Innovating from Drug Discovery through the Clinic: Novel Approaches to PD Therapeutic Development
Panelists discuss novel translational and clinical research from the Foundation’s research portfolio while sharing new and unpublished scientific results.
These events are brought to you by Biogen, MeiraGTx and Neuraly with additional support provided by AbbVie, Abcam, BBK, Bristol Myers Squibb, Charles River, IQVIA, Merck & Co., Inc., Kenilworth, NJ, USA and Sage Therapeutics.
Interested in Sponsorship Opportunities? Contact our Stakeholder Engagement team at firstname.lastname@example.org for information about 2021 opportunities.
Partner with Us
If you are interested in learning more about sponsorship opportunities for the webinar series, please reach out to email@example.com.